Las Condes 26 04

11 / 136

431
REFERENCIAS BIBLIOGRáFICAS
1. Rare Disease Act 2002. An Act to amend the Public Health
Service Act to establish an Office of Rare Diseases at the National
Institutes of Health, and for other purposes. November 6, 2002.
2. Orphan Drug Act 1983. An Act to amend the Federal Food, Drug,
and Cosmetic Act to facilitate the development of drugs for rare
diseases and conditions, and for other purposes. January 4,
1983.
3. Song P, Gao J, Inagaki Y, Kokudo N, Tang W. Intractable and rare
diseases research in Asia. Biosci Trends. 2012 Apr;6(2):48-51.
4. 2004 European Commission Health & Consumer Protection
Directorate-General Directorate C – Public Health and Risk
Assessment C2 - Health information. Useful Information on rare
diseases from an EU perspective.
5. 15/06/2015
6. Rare Diseases: Understanding this Public Health Priority 4/14
Eurordis, November 2005 –
7. 15/06/2015
8. Van de Laar FA, Bor H, van de Lisdonk EH. (2008). "Prevalence of
zebras in general practice: data from the Continuous Morbidity
Registration Nijmegen". Eur J Gen Pract. 14. Suppl 1 (s1): 44–56.
9. Gramar M. The Experience of the Rare Disorder Community
NORD survey, 2003.
10. Castilla EE, Mastroiacovo P. 2011. Very rare defects: What can
we learn? Am J Med Genet Part C Semin Med Genet 157:252-
261.
11. Van der Lee JH, WesselingJ, Tanck MW, Offringa M. Efficient ways
exist to obtain the optimal sample size in clinical trials in rare
diseases. J Clin Epidemiol 2008:61:324-330.
12. 15/06/2015
13. 15/06/2015
14. World Bank. What is empowerment?
WBSITE/EXTERNQL/TOPICS/EXTPOVERT/EXTEMPOWERMENT/0
(ACCESSED March, 2007).
15. Neuhauser D. The coming third healthcare revolution: personal
empowerment. Qual Manag Health Care 2003;12:171-84.
16. Ayme S, Kole A, Groft S Empowerment of patients: Lessons from
the rare diseases. Lancet 2008; 371:2048-51.
17. 15/06/2015
18. 15/06/2015
[LAS ENFERMEDADES RARAS - Dra. Fanny Cortés M.]